Login / Signup

Respiratory syntycial virus: Current treatment strategies and vaccine approaches.

Elena Margret ThornhillJessica SalporDavid Verhoeven
Published in: Antiviral chemistry & chemotherapy (2021)
Respiratory Syncytial Virus is a yearly respiratory virus that causes significant frequencies of morbidities, particularly in the young and elderly populations. However, preventive vaccines and/or treatment therapies are generally lacking, although much attention is now being placed on this virus. Moreover, there are now multiple strategies currently being explored in a race to the first licensed vaccine. While vaccines are being developed, multiple treatment strategies are being explored to attenuate the severity of infection and thus reduce hospitalization rates in vulnerable populations. This review outlines current strategies to prevent or treat this virus in the hopes of reducing significant human morbidity and mortality that occurs yearly with this seasonal virus.
Keyphrases
  • respiratory syncytial virus
  • endothelial cells
  • middle aged
  • disease virus
  • combination therapy
  • replacement therapy
  • pluripotent stem cells